Gehin JE, Warren DJ, Syversen SW, Lie E, et al. Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study. Scand J Rheumatol 2021;50:445-454.
PMID: 33650469